Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Trademark Search
NOVO NORDISK
REGISTERED
on 28 Mar 2024
Last Applicant/ Owned by
NOVO NORDISK A/S
Novo AlléDK-2880 Bagsvaerd
DK
Serial Number
2041272 filed on 03rd Apr 2020
Registration Number
TMA1226691 registered on 28th Mar 2024
Registration expiry Date
03rd Apr 2030Correspondent Address
1100-150 York StreetToronto
ONTARIO
CA
M5H3S5
NOVO NORDISK
Vienna Information
1 . 3 . 2
Other representations of the sunAutres représentations du soleil
1 . 3 . 8
Sun with animalsSoleil avec animaux
3 . 4 . 1
BovinesBovinés
3 . 4 . 4
Bisons, bullsBisons, taureaux
3 . 4 . 24
Animals of series IV stylized, in shadow or in silhouetteAnimaux de la série IV stylisés, en ombre ou en silhouette
3 . 4 . 26
Animals of Series IV standingAnimaux de la série IV debout
26 . 1 . 1
CirclesCercles
26 . 1 . 3
One circle or ellipseUn cercle ou une ellipse
29 . 1 . 4
BlueBleu
Trademark usage description
chemical preparations for use in the manufacturing of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical addi Read MoreClassification Information
Class [001]
Chemical preparations for use in the manufacturing of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals, cosmetics, hair lotions, disinfectants; diagnostic reagents for medical-scientific research use; chemicals for use in the oil refining industry.
Classification kind code
11
Class [005]
Pharmaceutical preparations for the treatment of diabetes and obesity; pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, namely, Epilepsy, Alzheimer's disease, cerebral palsy, Parkinson's disease, multiple sclerosis, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone replacement therapy and stem cells for medical purposes; drug delivery agents in the form of pre-filled syringes, transdermal patches and infusion pumps that provide controlled release of the active ingredients for a wide variety of pharmaceuticals, namely pharmaceuticals for the treatment and management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; chemical preparations for use in medical devices, namely pre-filled syringes, transdermal patches and infusion pumps to provide a controlled release of the active ingredients for a wide variety of pharmaceuticals, namely pharmaceuticals for the treatment and management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
Classification kind code
11
Class [009]
Electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material, namely instructional manuals, periodicals and textbooks in the field of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; downloadable electronic research reports, periodicals and guides containing results from clinical trials and studies in the field of prevention and treatment of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software applications for use with mobile devices for monitoring and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer hardware and software, for use with medical injection devices for collecting, transmitting, and displaying medical data; computer software for controlling and managing patient medical information; medical software for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software as a medical device (SaMD) for use in the diagnosis, management and treatment of sickle cell disease, diabetes, obesity, brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, and chronic kidney disease.
Classification kind code
11
Class [010]
Medical and surgical apparatus and instruments, namely, hypodermic syringes and pens; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations, namely, adhesive transdermal patches, sold empty, used to apply various pharmaceutical preparations to the body, injection instruments without needles, syringes for injections, intravenous administration sets, intravenous catheters, medical devices, namely, intravascular implants comprised of artificial material; medical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, namely, infusion pumps, medical infusion pumps, infusion pump controllers, adhesive infusion devices, namely, adhesive medical pads and patches used to affix medical devices to the body; digitally connected medical devices, namely, devices that dispense pharmaceuticals, specifically syringes for medical use, diabetes monitoring equipment for sampling and analyzing blood and body tissue, heart monitors, oxygen monitors, patient medical monitors for monitoring cardiac activity, blood pressure, CO2, vital signs, lung function, respiration monitors for use in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical and surgical apparatus and instruments, namely, syringes and injection instruments without needles for the administration of pharmaceuticals and the wireless transmission of patient medical information in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical devices, namely, automatic needle insertion instruments, protection caps for hypodermic syringes and medical pens; needles for injections; cartridges and capsules for administering pharmaceuticals.
Classification kind code
11
Class [041]
Educational services, namely, organizing and conducting educational programmes, coaching and training services for patients and healthcare professionals related to management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; arranging and conducting of conferences, congresses, seminars, symposiums and workshops related to the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
Classification kind code
11
Class [042]
Providing scientific information on diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing websites and mobile apps featuring technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer services, namely providing access to data concerning medical analysis and management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
Classification kind code
11
Class [044]
Providing medical services, namely medical clinic services, medical diagnostic services, medical nursing services, medical screening, medical testing services, medical care services, medical analysis services, medical evaluation services, and medical assistance services via websites and mobile apps for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing medical information and medical counselling in the fields of the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
Classification kind code
11
Mark Details
Serial Number
2041272
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 22 on 10th Nov 2021 | Search Recorded |
| Submitted for opposition 20 on 10th Nov 2021 | Examiner's First Report |
| Submitted for opposition 256 on 24th May 2021 | Notification of Possible Opposition Sent |
| Submitted for opposition 257 on 08th Oct 2020 | Designation Notification - Madrid Protocol |
| Submitted for opposition 257 on 23rd Jul 2020 | Designation Notification - Madrid Protocol |
| Submitted for opposition 1 on 22nd Jul 2020 | Created |
| Submitted for opposition 31 on 22nd Jul 2020 | Formalized |
| Submitted for opposition 228 on 03rd Apr 2020 | International Registration |
| Submitted for opposition 210 on 03rd Apr 2020 | IR Correction |
| Submitted for opposition 30 on 03rd Apr 2020 | Filed |